9 patents currently held
84 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Oct 2033. from the record
Of the 84 now held by other companies, 84 name Bruker Spatial Biology Inc. as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Oct 2033
Next term end
9
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Mar 2037 · High confidence
Also notable
Ends Apr 2034 · High confidence
Also notable
Ends Nov 2040 · High confidence
Methods, Systems and Devices for Selection and Generation of Genome Edited Clones
US 11,103,870
Cited by 13 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2037. A terminal disclaimer caps this term to an earlier patent's.
Providing DEP Manipulation Devices and Controllable Electrowetting Devices In The Same Microfluidic Apparatus
US 10,245,588
Cited by 14 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2034.
Systems and Methods for Analyses of Biological Samples
US 11,521,709
Cited by 8 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2040.
Formerly held, still cited
Notable
Ends Dec 2035 · High confidence
Cited by 80 later US patents, top 5% of utility patents granted in 2020 in our data. Protection runs to 2035. A terminal disclaimer caps this term to an earlier patent's.
now held by Bruker Spatial Biology, Inc.
Also notable
Ends Feb 2035 · High confidence
Cited by 71 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2035.
now held by Bruker Spatial Biology, Inc.
Also notable
Ends Mar 2037 · High confidence
Cited by 37 later US patents, top 10% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2037.
now held by Bruker Spatial Biology, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 6, 2026The maintenance fee for Sorting of T Lymphocytes in a Microfluidic Device (US 11,666,912) comes due Dec 6, 2026. Unpaid by Jun 7, 2027, it lapses early.
- 1 fee due Apr 17, 2027The maintenance fee for Methods, Systems and Kits for In-Pen Assays (US 11,789,016) comes due Apr 17, 2027. Unpaid by Oct 18, 2027, it lapses early.
- 1 fee due Sep 3, 2027The maintenance fee for Automated Identification of Assay Areas in a Microfluidic Device and Detection of Assay Positive Areas Based on Rate of Change of Image Light Intensity (US 10,578,630) comes due Sep 3, 2027. Unpaid by Mar 3, 2028, it lapses early.
Recent changes
- 2 terms have ended since Aug 16, 2026
What they patent
The 5 largest of its 9 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Systems and Methods for Analyses of Biological Samples | 1 in force | to Nov 2040 |
| Sorting of T Lymphocytes in a Microfluidic Device | 1 in force | to Sep 2040 |
| Freezing and Archiving Cells on a Microfluidic Device | 1 in force | to Aug 2038 |
| Methods of Producing Patient-Specific Anti-Cancer Therapeutics and Methods of Treatment Therefor | 1 in force | to Mar 2038 |
| Methods, Systems and Kits for In-Pen Assays | 1 in force | to Apr 2037 |
Patents held now
Soonest term end first.
Showing 1 to 9 of 9
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,921,055 | Detecting Cells Secreting A Protein Of Interest In force · High confidence | In force | High confidence | |
| US 10,245,588 | Providing DEP Manipulation Devices and Controllable Electrowetting Devices In The Same Microfluidic Apparatus In force · High confidence | In force | High confidence | |
| US 11,103,870 | Methods, Systems and Devices for Selection and Generation of Genome Edited Clones In force · High confidence | In force | High confidence | |
| US 11,789,016 | Methods, Systems and Kits for In-Pen Assays In force · High confidence | In force | High confidence | |
| US 10,712,344 | Methods of Producing Patient-Specific Anti-Cancer Therapeutics and Methods of Treatment Therefor In force · High confidence | In force | High confidence | |
| US 10,578,630 | Automated Identification of Assay Areas in a Microfluidic Device and Detection of Assay Positive Areas Based on Rate of Change of Image Light Intensity In force · High confidence | In force | High confidence | |
| US 12,102,083 | Freezing and Archiving Cells on a Microfluidic Device In force · High confidence | In force | High confidence | |
| US 11,666,912 | Sorting of T Lymphocytes in a Microfluidic Device In force · High confidence | In force | High confidence | |
| US 11,521,709 | Systems and Methods for Analyses of Biological Samples In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 84 patents in force now held by others · 10 patents ended · 35 applications pending · 36 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.